Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. MassDevice Q&A: Joe DeVivo
The newly minted CEO of AngioDynamics on his unique family business background, the importance of good neighbors and the company’s path along the mergers & acquisitions trail.
Sign up to get our free newsletters delivered straight to your inbox
2. J&J withdraws Sedasys appeal, re-opens PMA
Johnson & Johnson’s (NYSE:JNJ) Ethicon Endo-Surgery division will get another round with the FDA after its original pre-market application for the Sedasys computer-assisted personalized sedation system was denied.
1. CMS targets “unnecessary” med-tech
The Centers for Medicare & Medicaid Services unveil a pre-reimbursement review program in 11 states, aiming to reduce unnecessary payments by asking docs for up-front proof that the procedures are necessary.
